Evidence map›Paper›PMID 28285456›Full record

ReviewCurrent treatment options in cardiovascular medicine2017

Is VF an Ablatable Rhythm?

Ghassen Cheniti, Meleze Hocini, Ruairidh Martin, Frederic Sacher, Remi Dubois, Michel Haissaguerre, Pierre Jais

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current treatment options in cardiovascular medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Dominant vector changes during early wavebreak/spiral wave (Wiggers stage 1) in ventricular fibrillation: insights from the analysis of 100 electrophysiology studies.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2022
    Article
  4. Review
  5. Article
  6. Mapping and Ablation of Idiopathic Ventricular Fibrillation.Frontiers in cardiovascular medicine · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ghassen ChenitiHôpital Cardiologique du Haut-Lévêque, Université Bordeaux II, Bordeaux, France. ghassen.chniti@gmail.com.
Meleze HociniHôpital Cardiologique du Haut-Lévêque, Université Bordeaux II, Bordeaux, France.
Ruairidh MartinHôpital Cardiologique du Haut-Lévêque, Université Bordeaux II, Bordeaux, France.
Frederic SacherHôpital Cardiologique du Haut-Lévêque, Université Bordeaux II, Bordeaux, France.
Remi DuboisIHU LIRYC, Electrophysiology and Heart Modeling Institute, Bordeaux, France.
Michel HaissaguerreHôpital Cardiologique du Haut-Lévêque, Université Bordeaux II, Bordeaux, France.
Pierre JaisHôpital Cardiologique du Haut-Lévêque, Université Bordeaux II, Bordeaux, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

opinion statementVentricular fibrillation (VF) has traditionally been considered to be a disorganized arrhythmia not amenable to catheter ablation. However, a better understanding of the VF pathophysiology has allowed identification of targets for ablation. Ablation targeting the premature ventricular complexes which trigger VF was proven to be associated with high success rates and long-term freedom from VF recurrence. Recent mapping data has identified rotors, focal breakthroughs, and figure of eight re-entries as main drivers maintaining human VF. Most interestingly, the type and the spatiotemporal behavior of these drivers are reproducible between different VF episodes. In addition, drivers are usually clustered at the scar borders. This has ushered in a new era of ablation targeting the VF substrate and the drivers maintaining VF with promising results.

Indexed as

AblationDriversSubstrateTriggersVentricular fibrillation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.